On May 16, 2018, the House Committee on Ways and Means ordered seven bills to be reported related to the nation’s response to the opioid epidemic. Because the bills are related, CBO is publishing a single comprehensive document that includes estimates for each piece of legislation.
H.R. 5723, the Expanding Oversight of Opioid Prescribing and Payment Act of 2018, would require the Medicare Payment Advisory Commission to report to the Congress on payments for pain treatment, incentives for prescribing opioids in inpatient and outpatient settings, and documented tracking of opioid use from Medicare claims data. CBO estimates that producing such a report would cost less than $500,000 over the 2019-2023 period.
